Clinical Trials on Hyperlipoproteinemia Type II in United States
Total 28272 results
-
Griffin HospitalEgg Nutrition CenterRecruitingHyperlipidemiasUnited States
-
Brigham and Women's HospitalAmgenRecruiting
-
Oregon Health and Science UniversityCompletedHyperlipidemiasUnited States
-
Valeritas, Inc.Unknown
-
East Carolina UniversityCompletedDiabetes Mellitus Type IIUnited States
-
AstraZenecaCompletedType II Diabetes MellitusUnited States
-
Walter Reed National Military Medical CenterCompletedType II Diabetes MellitusUnited States
-
Mountain Diabetes and Endocrine CenterCompletedDiabetes Mellitus, Type IIUnited States
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType II Diabetes MellitusUnited States
-
Ferzli, George S., M.D. F.A.C.S.UnknownType II DiabetesUnited States
-
Ageless Regenerative InstituteWithdrawnDiabetes Mellitus Type IIUnited States
-
Healthy Drink Discoveries, Inc.CompletedHyperlipidemiaUnited States
-
REGENXBIO Inc.Active, not recruitingMucopolysaccharidosis Type II (MPS II)United States, Brazil
-
Medical University of South CarolinaCompleted
-
Washington University School of MedicineCompletedDiabetes Mellitus, Type IIUnited States
-
Tuscaloosa Research & Education Advancement CorporationAmerican Society of Health-System Pharmacists Research and Education FoundationCompletedHypercholesterolemia | HyperlipidemiaUnited States
-
Vanderbilt University Medical CenterTerminated
-
Duke UniversityCompleted
-
AstraZenecaCompleted
-
University of California, San FranciscoTufts University; Vanderbilt University; University of Guelph; University of L'AquilaCompletedHyperlipidemiaUnited States
-
Arizona State UniversityTakeda Pharmaceuticals North America, Inc.UnknownType II Diabetes MellitusUnited States
-
Emory UniversityCenters for Disease Control and PreventionCompleted
-
US Department of Veterans AffairsCompletedObesity | Type 2 Diabetes | HyperlipidemiaUnited States
-
University of Colorado, DenverDaiichi Sankyo, Inc.CompletedDyslipidemia | HyperlipidemiaUnited States
-
Duke UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Children...Completed
-
University of California, San FranciscoNovartisTerminatedLow Grade Glioma | World Health Organization (WHO) Grade II Astrocytomas | Oligodendrogliomas | Mixed OligoastrocytomasUnited States
-
Mike O'Callaghan Military HospitalCompletedType II Diabetes MellitusUnited States
-
University of PennsylvaniaCompleted
-
Brigham and Women's HospitalSanofiCompletedCardiovascular Disease | Type II DiabetesUnited States
-
University of California, San FranciscoCompletedDiabetes Type IIUnited States
-
University of ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedKrabbe Disease | Mucopolysaccharidosis Type II (MPS II) | Mucopolysaccharidosis Type I (MPS I) | Mucopolysaccharidosis Type III (MPS III) | Mucopolysaccharidosis Type VI (MPS VI)United States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Pompe DiseaseUnited States
-
AstraZenecaCompletedType II Diabetes MellitusUnited States
-
Pharmena North AmericaCompletedHyperlipidemiaUnited States
-
Geisinger ClinicNational Human Genome Research Institute (NHGRI)Active, not recruitingLynch Syndrome | Familial Hypercholesterolemia | Hereditary Breast and Ovarian Cancer SyndromeUnited States
-
Northwestern UniversityUniversity of Illinois at ChicagoCompletedDiabetes Mellitus Type II | Diabetes Mellitus Type IUnited States
-
Oregon Health and Science UniversityCompletedPrimary Health Care | Type II Diabetes | Behavioral HealthUnited States
-
Frank LiebermanUniversity of MinnesotaCompletedHigh Risk WHO Grade II Glioma | Recurrent/Post-Chemotherapy WHO Grade II GliomaUnited States
-
University of Mississippi Medical CenterCompletedBlood Pressure | Oxidative Stress | HyperlipidemiaUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Stanley Medical Research InstituteCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedInsulin Resistance | Diabetes Mellitus, Type IIUnited States
-
The Cleveland ClinicRecruitingPrimary Hyperparathyroidism | Type 2 DiabetesUnited States
-
National Cancer Institute (NCI)CompletedGlioma | Glioblastoma Multiforme | Giant Cell Glioblastoma | Oligodendrogliomas | Astrocytoma, Grades II, III and IVUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II)United States, Russian Federation, United Kingdom, Bulgaria, India, Ukraine
-
East Carolina UniversityJohnson & JohnsonCompletedObesity | Type II Diabetes MellitusUnited States
-
Beth Israel Medical CenterCompletedBi-polar II DisorderUnited States
-
Genzyme, a Sanofi CompanyTerminatedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease | Glycogenesis 2 Acid Maltase DeficiencyUnited States, Israel
-
Ohio State UniversityEmory University; Nationwide Children's HospitalTerminated